What is Array Instruments?
Array instruments used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds which are attached to a solid substrate. Array instruments market is growing owing to increasing demand for diagnosis of the particular type of metabolic diseases, cancer, and post-natal diseases. This instruments helps to analyses gene expression levels and genotype multiple regions. Further increasing government initiatives towards developing healthcare infrastructure and increasing research and development by market leaders expected to drive the array instrument market over the forecasted period.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Thermo Fischer Scientific (United States), Illumina Inc. (United States), Agilent Technologies (United States), Molecular Devices (United States), Array It Corporation (United States), Bio-Rad Laboratories (United States), Array Jet (United Kingdom), Orla Protein Technologies (United Kingdom), Oxford Gene Technology (United Kingdom), Sigma Aldrich (United States), OriGene Technologies (United States), Asterand Bioscience (United States), ProteoGenix (France) and Ray Biotech (United States) |
CAGR | 5.5% |
The study covers a detailed analysis segmented by key business segments i.e. by type (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays and Others) , by application (Gene Expression, Genotyping, Whole Genome Cytogenetics, Drug Discovery and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Array Instruments market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Array Instruments market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Thermo Fischer Scientific (United States), Illumina Inc. (United States), Agilent Technologies (United States), Molecular Devices (United States), Array It Corporation (United States), Bio-Rad Laboratories (United States), Array Jet (United Kingdom), Orla Protein Technologies (United Kingdom), Oxford Gene Technology (United Kingdom), Sigma Aldrich (United States), OriGene Technologies (United States), Asterand Bioscience (United States), ProteoGenix (France) and Ray Biotech (United States).
Market Overview:
In May 2023, Thermo Fischer Scientific acquired the diagnostic firm Binding Site from private-equity group Nordic Capital, adding to its array of product offerings. This acquisition done in an all-cash transaction for USD 2.6 billion. This acquisition helped company to expand its presence in array instruments market
Numerous players are present in the array instrument market hence fragmented nature of the market. Some of the market leaders are Thermo Fischer Scientific, Illumina Inc. Agilent Technologies and others. Market leaders are investing in the automation of systems for developing advanced analysis techniques in the near future.
Influencing Trend:
Emphasizing on Customize Treatments for Certain Deadly Diseases such as Cancer and Increasing Use of Protein Expression Profiling in Proteomics
Market Growth Drivers:
Enhanced the Process of Single Nucleotide Polymorphism (SNP) Analysis and Gene Expression and Provides Accuracy and Precision in Disease Diagnosis and Drug Discovery
Challenges:
Making Cost Effective Tissue Microarrays
Restraints:
High Cost Associated With Array Instrument and Lack of Expertise to Operate Microarray Technology
Opportunities:
Increasing Demand for Automatic Image Analysis in the Healthcare Industry and Development in Advances Techniques for Disease Diagnosis
Key highlights of the Global Array Instruments market Study:
CAGR of the market during the forecast period 2022-2028
In-depth information on growth factors that will accelerate the Array Instruments market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Array Instruments market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Array Instruments Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Array Instruments market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Array Instruments market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Array Instruments Product Manufacturers and Distributors, Research Laboratories, Healthcare Institutes, Market Research Firms, Government Agencies and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.